Care Partner Assessment Tool for Dementia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Care Partner Hospital Assessment Tool (CHAT) can improve care for people with dementia after hospital discharge. The study focuses on care partners assisting a hospitalized loved one with Alzheimer's or similar dementia. Participants will either continue with usual care or use the CHAT tool to communicate their needs for enhanced post-hospital support. This trial suits those providing unpaid care to a hospitalized adult with dementia. As an unphased trial, it offers a unique opportunity to contribute to innovative care strategies for dementia patients.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that the Care Partner Hospital Assessment Tool is safe for use with dementia care partners?
Research has shown that the Care Partner Hospital Assessment Tool (CHAT) is safe to use. This questionnaire assists family members or friends in caring for people with dementia after hospital discharge.
Studies have found that healthcare professionals and caregivers collaborated to create this tool, ensuring it meets real needs without causing harm. No reports indicate negative effects from using this tool, as it involves only answering questions to enhance care.
In summary, CHAT is easy to use and poses no known risks to participants.12345Why are researchers excited about this trial?
Researchers are excited about the Care Partner Hospital Assessment Tool (CHAT-AD) for dementia because it offers a personalized approach to post-hospital care. Unlike standard care, which often provides a one-size-fits-all solution, CHAT-AD involves asking caregivers specific questions about their needs to better support their loved ones after discharge. This method aims to tailor resources and guidance to each unique situation, potentially improving outcomes for both patients and their caregivers by addressing individual challenges more effectively.
What evidence suggests that the Care Partner Hospital Assessment Tool is effective for improving care for dementia patients?
Research shows that the Care Partner Hospital Assessment Tool (CHAT) can assist those caring for people with dementia. In this trial, participants in the experimental arm will use the adapted version for dementia care, called CHAT-AD, which helps identify care partners' needs when their loved ones leave the hospital. Early results suggest it might improve home care. Although researchers are still studying its effectiveness for dementia care, the tool aims to provide better support and outcomes for both patients and their care partners. Participants in the other arm will receive standard care without using CHAT-AD.12367
Who Is on the Research Team?
Beth Fields, PhD
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for adult care partners who provide unpaid assistance to a hospitalized relative or partner with Alzheimer's disease or related dementias (ADRD). Participants must be over 18 and speak English. It's not suitable for those who cannot communicate in English.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Adaptation and Co-design
Adaptation of CHAT-AD through co-design sessions with stakeholders
Recruitment and Randomization
Recruitment of care partners and randomization into intervention or control groups
Intervention
Participants receive either the adapted CHAT-AD intervention or standard care
Follow-up
Participants are monitored for outcomes such as care partner satisfaction and burden
What Are the Treatments Tested in This Trial?
Interventions
- Care Partner Hospital Assessment Tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator